Jefferies Starts Campbell Soup (CPB) at Hold
Tweet Send to a FriendGet Alerts CPB Hot Sheet
Price: $45.85 +0.26%
Rating Summary:
1 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 21
Rating Summary:
1 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 21
Trade CPB Now!
Jefferies initiates coverage on Campbell Soup (NYSE: CPB) with a Hold. PT $36.00.
"Even though the downside is likely limited, in our view, the co.’s turnaround is not complete and headwinds remain strong," said analyst Thilo Wrede.
"Over time, bolder innovation, better packaging and a renewed focus on marketing should give the soup business a chance to halt its multi-year decline. But at the same time, margin concerns remain, given the challenging macro environment."
For an analyst ratings summary and ratings history on Campbell Soup click here. For more ratings news on Campbell Soup click here.
Shares of Campbell Soup closed at $32.77 yesterday, with a 52 week range of $29.69-$34.58.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
"Even though the downside is likely limited, in our view, the co.’s turnaround is not complete and headwinds remain strong," said analyst Thilo Wrede.
"Over time, bolder innovation, better packaging and a renewed focus on marketing should give the soup business a chance to halt its multi-year decline. But at the same time, margin concerns remain, given the challenging macro environment."
For an analyst ratings summary and ratings history on Campbell Soup click here. For more ratings news on Campbell Soup click here.
Shares of Campbell Soup closed at $32.77 yesterday, with a 52 week range of $29.69-$34.58.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- Campbell Soup (CPB) to Acquire Kelsen Group A/S
- UPDATE: UBS Starts Insmed (INSM) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Jefferies & CoLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

